Skip to content
value.today

Puma Biotechnology, Inc. vs Urovant Sciences

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Puma Biotechnology, Inc. and Urovant Sciences are worth about the same: $508 M and $512 M (market caps of Oct 19, 2026 for Puma Biotechnology, Inc. and Jan 1, 2021 for Urovant Sciences). Urovant Sciences's value is the last on file, from Jan 1, 2021: no market-data feed is connected for its exchange yet.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

040811211622020202120222023202420252026Puma Biotechnology, Inc. 154Urovant Sciences 111

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$0B$0B$0B$0B2019202020212022202320242025Puma Biotechnology, Inc. $0B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasurePuma Biotechnology, Inc.
PBYI · #12,484 in the world
Urovant Sciences
UROV
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology
Founded——
Size
Market cap$508 M$512 M*
Revenue$228 M—
Net income$31 M—
Valuation
P/E ratio21.3×—
Price to sales2.2×—
Price to book3.9×—
Free cash flow yield8.2%—
Profitability
Gross margin74.5%—
Operating margin16.3%—
Net margin13.6%—
Return on equity28.0%—
Return on invested capital30.3%—
Growth
Revenue growth-0.9%—
Revenue growth, 3 years a year0.1%—
Earnings per share growth-1.6%—
Financial strength
Debt to equity0.2×—
Net debt to EBITDA-0.1×—
Cash
Free cash flow margin18.3%—
Strength scores
Piotroski F-score7 of 9—
Altman Z-score zonedistress—
Data as ofMarket cap Oct 2026; ratios FY2025Market cap Jan 2021

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, Puma Biotechnology, Inc. or Urovant Sciences?

Puma Biotechnology, Inc. and Urovant Sciences are worth about the same: $508 M and $512 M (market caps of Oct 19, 2026 for Puma Biotechnology, Inc. and Jan 1, 2021 for Urovant Sciences). Urovant Sciences's value is the last on file, from Jan 1, 2021: no market-data feed is connected for its exchange yet.

Sources#

Every figure on this page comes from these, with the date shown next to it.